Each one in plain English, with the numbers worked through for a shareholder.
15 July 2024capital raising announcement▼ Bad
Second Acuity at-the-market draw: A$1.1M from 7.05M shares at A$0.156, an 8.8% discount to the 15-day VWAP. Collateral shares were topped up to 15M. A$3.35M drawn in total, A$11.65M remains, versus the A$0.283 first draw.
What it means for a shareholder
7.0m new shares at A$0.156 to raise about A$1.1m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
HMW Phase 1 is about 40% complete with over 2,800t LCE in ponds. Construction has been slowed to preserve cash, so first production moves from H1 2025 to H2 2025. Offtake partners are shortlisted, with a sales agreement and funding package still being sought.
24 June 2024director officer appointment● NeutralMajor
Ross Dinsdale, previously CFO of Mallee Resources, is appointed CFO from 10 July 2024. Galan says his financing background suits its ongoing offtake and funding negotiations. He follows Graeme Fox as CFO in the context.
Galan has firm commitments for a A$14M placement at A$0.23 per share, a 20.7% discount to the A$0.29 close, with one option (A$0.35, two years) per two shares. Funds support HMW Phase 1 while debt and prepayment funding is negotiated. Directors take about A$1M in a second tranche.
Invitation to a shareholder webinar on 21 May 2024 with the Managing Director and Daniel Jimenez giving a company update. No new information in the notice itself.
Galan draws on the Acuity facility for the first time, raising A$2.25M by setting off 7.95M collateral shares at A$0.283, a 5.7% discount to the A$0.30 close. That is well below the A$0.46 placement price.
HMW Phase 1 is 33% complete, with ponds 45% built and about 1,000t LCE in Ponds 1 and 2. Pond 3 is filling and Pond 4 earthworks have begun. Production stays on track for H1 2025, with Phase 1 cost-saving options being quantified. Glencore due diligence continues.
ASX lifts the suspension of Galan shares on release of the government permitting announcement. Administrative; ends the suspension that began on 17 April.
Catamarca's governor signed a commercial agreement supporting permits to sell lithium chloride concentrate locally or export it. It lifts the proposed royalty to 7% and commits Galan to downstream processing after 4 years. Galan says it is a prerequisite for Phase 2 permits; still to be legislated.
Galan extends its voluntary suspension to 22 April 2024 or until release of the announcement on government permitting. Procedural; no new information given.
Galan's shares are placed in voluntary suspension at the company's request, pending an announcement on government permitting. The request runs to 19 April or until the announcement is released.
Galan signs a A$15M standby equity facility with Acuity Capital, available until 31 January 2029, at Galan's discretion with no obligation to use it. It issued 15M collateral shares at nil cash as security. Issue price would be at up to a 10% discount to VWAP.
Secondary trading notice for the 15,000,000 collateral shares issued to Acuity Capital on 12 April 2024 under the standby equity facility. Administrative only.
Addendum to the 27 March resource release supplying disclosure items the original lacked under listing rules: no cut-off grade applied (grades below 400mg/L are 0.02% of the resource), conversion factors, and pilot test work history. No change to the resource figures.
27 Mar 2024capital raising announcement▲ GoodMajor
The Share Purchase Plan drew just over A$4M of applications against a A$1.5M target, and Galan lifted it to A$4.003M. It will issue 8,702,150 shares (2.2% of capital) at A$0.46, each with a free $0.65 option.
Singapore investor presentation, March 2024, restating known Phase 1 and Phase 2 study results and referring to the 27 March resource update. The text shown contains no new information.
Prospectus for the free listed options ($0.65, expiring 20 March 2029) attached to the A$0.46 raising: up to 35.9M for placement investors, 4.8M for directors (subject to approval) and 8.7M for SPP participants. No funds are raised.
Total resource rises 18% to 8.6Mt LCE at 859mg/L Li (previously 7.3Mt), mainly from adding the Catalina tenure (~1.3Mt LCE). The HMW Measured category is 4.7Mt LCE at 866mg/L. This is Galan's fourth major upgrade since the March 2020 maiden resource.
Filling of Pond 2 has begun, and Pond 1 holds about 500t LCE. Ten production wells are done, against six needed for Phase 1. Glencore due diligence continues, with outcomes to be announced on completion.
Galan says a Catamarca court ruling halting new permits in the Los Patos River area does not affect its granted Phase 1 permits, and it expects no impact on Phase 2, as it does not plan to use Los Patos water. This is the company's own assessment.
Half-year to 31 December 2023: loss of A$4.55M (prior year A$2.96M) and cash of A$15.9M, down from A$45.2M at June 2023. The 550,000 shares issued on 4 October were part-payment for Canadian James Bay tenements.
The Share Purchase Plan closing date is extended to 22 March 2024, with results due 26 March and shares issued 28 March. A timetable change to the A$0.46 offer; no change to its terms.
Exploration licence E70/4629 is granted for five years, about 43 km2 and less than 30 km south of Greenbushes, lifting Greenbushes South to 315 km2. A maiden exploration campaign is planned for H2 2024. Early-stage, with no results yet.
Pond 1 earthworks and liner (2.4km) are complete, and filling of the rest of the pond and evaporation have started. Pond 2 earthworks are 65% done. This moves Phase 1 toward the H1 2025 target; Glencore due diligence continues.